Eileen Brown

2.6k total citations
31 papers, 2.0k citations indexed

About

Eileen Brown is a scholar working on Public Health, Environmental and Occupational Health, Cardiology and Cardiovascular Medicine and Psychiatry and Mental health. According to data from OpenAlex, Eileen Brown has authored 31 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Public Health, Environmental and Occupational Health, 8 papers in Cardiology and Cardiovascular Medicine and 8 papers in Psychiatry and Mental health. Recurrent topics in Eileen Brown's work include Menstrual Health and Disorders (9 papers), Antiplatelet Therapy and Cardiovascular Diseases (7 papers) and Bipolar Disorder and Treatment (6 papers). Eileen Brown is often cited by papers focused on Menstrual Health and Disorders (9 papers), Antiplatelet Therapy and Cardiovascular Diseases (7 papers) and Bipolar Disorder and Treatment (6 papers). Eileen Brown collaborates with scholars based in United States, Canada and Poland. Eileen Brown's co-authors include Meir Steiner, Mary Ann MacDougall, K.M.A. Welch, Michael Chopp, Robert W. Baker, Graham J. Emslie, John H. Heiligenstein, Mary Nilsson, Jennie G. Jacobson and Karen Dineen Wagner and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and American Journal of Psychiatry.

In The Last Decade

Eileen Brown

31 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eileen Brown United States	16	637	569	545	300	218	31	2.0k
Kwangik Hong United States	25	178 0.3×	194 0.3×	654 1.2×	148 0.5×	150 0.7×	29	2.8k
Beatrice Bortolato Brazil	13	196 0.3×	1.1k 2.0×	432 0.8×	396 1.3×	286 1.3×	15	2.7k
Martin P. Szuba United States	24	385 0.6×	505 0.9×	230 0.4×	258 0.9×	283 1.3×	41	2.2k
Martin Birkett United States	20	117 0.2×	773 1.4×	576 1.1×	371 1.2×	367 1.7×	26	2.3k
Joseph S. Goveas United States	28	166 0.3×	647 1.1×	471 0.9×	469 1.6×	115 0.5×	61	2.6k
M. F. Folstein United States	24	111 0.2×	805 1.4×	285 0.5×	503 1.7×	223 1.0×	37	2.1k
Mohammad Alsuwaidan Canada	22	189 0.3×	881 1.5×	355 0.7×	266 0.9×	552 2.5×	37	2.2k
Lauren Sham Canada	5	280 0.4×	489 0.9×	246 0.5×	392 1.3×	292 1.3×	9	3.7k
Jenny Bearn United Kingdom	21	508 0.8×	395 0.7×	149 0.3×	113 0.4×	229 1.1×	35	1.6k
Simon Kung United States	25	198 0.3×	625 1.1×	433 0.8×	79 0.3×	570 2.6×	102	2.0k

Countries citing papers authored by Eileen Brown

Since Specialization

Citations

This map shows the geographic impact of Eileen Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eileen Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eileen Brown more than expected).

Fields of papers citing papers by Eileen Brown

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eileen Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eileen Brown. The network helps show where Eileen Brown may publish in the future.

Co-authorship network of co-authors of Eileen Brown

This figure shows the co-authorship network connecting the top 25 collaborators of Eileen Brown. A scholar is included among the top collaborators of Eileen Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eileen Brown. Eileen Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dudek, Dariusz, Artur Dziewierz, Petr Widimský, et al.. (2015). Impact of prasugrel pretreatment and timing of coronary artery bypass grafting on clinical outcomes of patients with non-ST-segment elevation myocardial infarction: From the A Comparison of Prasugrel at PCI or Time of Diagnosis of Non–ST-Elevation Myocardial Infarction (ACCOAST) study. American Heart Journal. 170(5). 1025–1032.e2. 13 indexed citations

Widimský, Petr, Zuzana Moťovská, Leonardo Bolognese, et al.. (2015). Predictors of bleeding in patients with acute coronary syndromes treated with prasugrel. Heart. 101(15). 1219–1224. 12 indexed citations

Montalescot, Gilles, Jean‐Philippe Collet, Patrick Ecollan, et al.. (2014). Effect of Prasugrel Pre-Treatment Strategy in Patients Undergoing Percutaneous Coronary Intervention for NSTEMI. Journal of the American College of Cardiology. 64(24). 2563–2571. 47 indexed citations

Nicolau, José Carlos, Deepak L. Bhatt, Matthew T. Roe, et al.. (2013). THE ASSOCIATION BETWEEN CONCOMITANT PROTON-PUMP INHIBITOR USE AND CLINICAL OUTCOMES IN PATIENTS WITH ACUTE CORONARY SYNDROMES TREATED WITH PRASUGREL VERSUS CLOPIDOGREL AND MANAGED WITHOUT REVASCULARIZATION: INSIGHTS FROM THE TRILOGY ACS STUDY. Journal of the American College of Cardiology. 61(10). E39–E39. 2 indexed citations

Chin, Chee Tang, Matthew T. Roe, Keith A.A. Fox, et al.. (2010). Study design and rationale of a comparison of prasugrel and clopidogrel in medically managed patients with unstable angina/non–ST-segment elevation myocardial infarction: The TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial. American Heart Journal. 160(1). 16–22.e1. 98 indexed citations

Brown, Eileen. (2010). Working the Crowd. 2 indexed citations

Fava, Maurizio, James M. Martinez, Lauren B. Marangell, et al.. (2007). The Efficacy and Tolerability of Duloxetine in the Treatment of Anxious Versus Non-Anxious Depression: A Post-Hoc Analysis of an Open-Label Outpatient Study. Annals of Clinical Psychiatry. 19(3). 187–195. 20 indexed citations

Perlis, Roy H., Eileen Brown, Robert W. Baker, & Andrew A. Nierenberg. (2006). Clinical Features of Bipolar Depression Versus Major Depressive Disorder in Large Multicenter Trials. American Journal of Psychiatry. 163(2). 225–231. 169 indexed citations

Brown, Eileen, et al.. (2006). Clinical relevance of depressive symptom improvement in bipolar I depressed patients. Journal of Affective Disorders. 92(2-3). 261–266. 20 indexed citations

10.

Suppes, Trisha, Eileen Brown, Leslie M. Schuh, Robert W. Baker, & Mauricio Tohen. (2005). Rapid versus non-rapid cycling as a predictor of response to olanzapine and divalproex sodium for bipolar mania and maintenance of remission: Post hoc analyses of 47-week data. Journal of Affective Disorders. 89(1-3). 69–77. 33 indexed citations

11.

Baker, Robert W., Eileen Brown, Hagop S. Akiskal, et al.. (2004). Efficacy of olanzapine combined with valproate or lithium in the treatment of dysphoric mania. The British Journal of Psychiatry. 185(6). 472–478. 40 indexed citations

12.

Steiner, Meir, Eileen Brown, Paula T. Trzepacz, et al.. (2003). Fluoxetine improves functional work capacity in women with premenstrual dysphoric disorder. Archives of Women s Mental Health. 6(1). 71–77. 50 indexed citations

13.

Steiner, Meir, Mary Ann MacDougall, & Eileen Brown. (2003). The premenstrual symptoms screening tool (PSST) for clinicians. Archives of Women s Mental Health. 6(3). 203–209. 423 indexed citations

14.

Emslie, Graham J., John H. Heiligenstein, Karen Dineen Wagner, et al.. (2002). Fluoxetine for Acute Treatment of Depression in Children and Adolescents: A Placebo-Controlled, Randomized Clinical Trial. Journal of the American Academy of Child & Adolescent Psychiatry. 41(10). 1205–1215. 427 indexed citations

15.

Cohen, Louise Glassner, et al.. (2002). Predictors of response to luteal phase fluoxetine treatment of PMDD. European Neuropsychopharmacology. 12. 176–176. 4 indexed citations

16.

Brown, Eileen, et al.. (2002). Weekly luteal-phase dosing with enteric-coated fluoxetine 90 mg in premenstrual dysphoric disorder: A randomized, double-blind, placebo-controlled clinical trial. Clinical Therapeutics. 24(3). 417–433. 72 indexed citations

17.

Cohen, Lee S., et al.. (2002). Premenstrual Daily Fluoxetine for Premenstrual Dysphoric Disorder. Obstetrics and Gynecology. 100(3). 435–444. 3 indexed citations

18.

Mattiello, James, Jeffrey L. Evelhoch, Eileen Brown, A. Paul Schaap, & Fred W. Hetzel. (1990). Effect of photodynamic therapy on RIF‐1 tumor metabolism and blood flow examined by ³¹P and ²H NMR spectroscopy. NMR in Biomedicine. 3(2). 64–70. 25 indexed citations

19.

Chopp, Michael, K. -L. Ho, Mary O. Dereski, et al.. (1989). Transient hyperthermia protects against subsequent forebrain ischemic cell damage in the rat. Neurology. 39(10). 1396–1396. 231 indexed citations

20.

Levine, Murray, et al.. (1978). Adapting the jury trial for program evaluation: A report of an experience. Evaluation and Program Planning. 1(3). 177–186. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact